Evaluate the Real-World Safety Outcomes and Clinical Efficacy of Ponatinib and Other Tyrosine Kinase Inhibitors among Chronic Myeloid Leukemia Patients First published 15/02/2023 Last updated 02/07/2024 EU PAS number:EUPAS50308 Study Finalised